Nathan Treybeck
Stock Analyst at Wells Fargo
(0.60)
# 4,330
Out of 5,133 analysts
75
Total ratings
27.9%
Success rate
-6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Nathan Treybeck
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRTC iRhythm Holdings | Reiterated: Buy | $150 → $135 | $91.91 | +46.88% | 23 | Nov 6, 2026 | |
| LMAT LeMaitre Vascular | Reiterated: Hold | $104 → $86 | $78.29 | +9.85% | 9 | Nov 5, 2026 | |
| RMD ResMed | Rated: Hold | $215 → $250 | $239.53 | +4.37% | 5 | Oct 30, 2026 | |
| SOLV Solventum | Reiterated: Hold | $89 | $89.08 | -0.09% | 1 | Aug 6, 2026 | |
| PRCT PROCEPT BioRobotics | Downgraded: Hold | $34 → $19 | $23.80 | -20.17% | 26 | Aug 5, 2026 | |
| ITGR Integer Holdings | Downgraded: Hold | $132 → $80 | $126.70 | n/a | 11 | Oct 23, 2025 |
iRhythm Holdings
Nov 6, 2026
Reiterated: Buy
Price Target: $150 → $135
Current: $91.91
Upside: +46.88%
LeMaitre Vascular
Nov 5, 2026
Reiterated: Hold
Price Target: $104 → $86
Current: $78.29
Upside: +9.85%
ResMed
Oct 30, 2026
Rated: Hold
Price Target: $215 → $250
Current: $239.53
Upside: +4.37%
Solventum
Aug 6, 2026
Reiterated: Hold
Price Target: $89
Current: $89.08
Upside: -0.09%
PROCEPT BioRobotics
Aug 5, 2026
Downgraded: Hold
Price Target: $34 → $19
Current: $23.80
Upside: -20.17%
Integer Holdings
Oct 23, 2025
Downgraded: Hold
Price Target: $132 → $80
Current: $126.70
Upside: n/a